Stay updated on Nivolumab + HF10 for Resectable Melanoma Clinical Trial

Sign up to get notified when there's something new on the Nivolumab + HF10 for Resectable Melanoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Nivolumab + HF10 for Resectable Melanoma Clinical Trial page

  1. Check
    3 days ago
    Change Detected
    Summary
    Revision updated to v3.4.1. Melanoma and related topics (MedlinePlus Genetics) were removed, and the reference to Revision: v3.4.0 was deleted.
    Difference
    0.2%
    Check dated 2026-02-05T13:43:39.000Z thumbnail image
  2. Check
    11 days ago
    No Change Detected
  3. Check
    18 days ago
    Change Detected
    Summary
    The page now lists Melanoma as a topic and adds a related topics link to MedlinePlus Genetics. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.2%
    Check dated 2026-01-22T06:24:36.000Z thumbnail image
  4. Check
    25 days ago
    Change Detected
    Summary
    The page now includes a new revision note (Revision: v3.3.4) and removes certain topics (Melanoma and MedlinePlus Genetics) as well as the prior revision tag (Revision: v3.3.3). These updates are metadata/navigation changes and do not affect the trial's core details, eligibility criteria, or results.
    Difference
    0.2%
    Check dated 2026-01-15T03:04:47.000Z thumbnail image
  5. Check
    39 days ago
    Change Detected
    Summary
    Added Melanoma as a related topic and MedlinePlus Genetics as related topics on the page; these are contextual and do not alter core study content, eligibility criteria, or outcomes. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.2%
    Check dated 2025-12-31T17:14:59.000Z thumbnail image
  6. Check
    46 days ago
    Change Detected
    Summary
    Added Utah to the Locations section and updated the revision to v3.3.3. Removed Utah Locations and several related topics, including HHS Vulnerability Disclosure, MedlinePlus Genetics, and Melanoma.
    Difference
    0.4%
    Check dated 2025-12-24T14:45:40.000Z thumbnail image
  7. Check
    61 days ago
    Change Detected
    Summary
    Added Melanoma as a related topic and MedlinePlus Genetics as related topics on the page. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.2%
    Check dated 2025-12-10T00:40:23.000Z thumbnail image

Stay in the know with updates to Nivolumab + HF10 for Resectable Melanoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Nivolumab + HF10 for Resectable Melanoma Clinical Trial page.